Latest filing published 10 Dec 2008 for RespireRx Pharmaceuticals Inc., €1,741.
Insider track record
No signal scores available.
Robert Allnutt: trading record in brief
Robert Allnutt is a declared insider of RespireRx Pharmaceuticals Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 30 November 2006 to 9 December 2008, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 10 December 2008: an option exercise of €1,741, in RespireRx Pharmaceuticals Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Allnutt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$0.375Common StockSEC:0001181431-08-066726:0
- 6,000 shares@ US$0.375Common StockSEC:0001181431-07-074120:0
- 6,000 shares@ US$0.375Common StockSEC:0001181431-06-066726:0
3 of 3 declarations